InvestorsHub Logo
Followers 3
Posts 217
Boards Moderated 0
Alias Born 10/16/2010

Re: None

Wednesday, 02/12/2014 6:50:37 PM

Wednesday, February 12, 2014 6:50:37 PM

Post# of 15766
A Vista Partners’ Commentary “Interview with Mast Therapeutics’ (MSTX) CEO Brian Culley Regarding FDA’s Recent Public Meeting “Patient-Focused Drug Development for Sickle Cell Disease” - See more at: http://www.vistapglobal.com/2014/02/mstx/#sthash.TCyMccqf.8dOX3d7d.dpuf